All News

2021

July

Featured News / Jul 27, 2021

Novartis receives FDA Orphan Drug Designation for NIS793 in pancreatic cancer

Read More
View on Novartis Basel campus
Featured News / Jul 21, 2021

Novartis Financial Results – Q2 2021

Novartis announced the company’s financial results for the second quarter and first half of 2021.

Read More
Key Release / Jul 21, 2021

Novartis delivered strong Q2 performance, driven by momentum of key growth brands. FY 2021 guidance unchanged.

Read More
Story / Jul 20, 2021

In your neighborhood: a community-based approach to health equity in the US

Patrice Matchaba shares how a lifetime of experience helped shape an effort to address healthcare disparities.

Read More
Featured News / Jul 20, 2021

Beacon of Hope: Addressing health disparities through holistic community-based collective action

Read More
Media Release / Jul 20, 2021

Novartis pledges 10-year commitment with Morehouse School of Medicine, 26 Historically Black Colleges, Universities, Medical Schools and other leading organizations to co-create effective, measurable solutions for health equity

Read More
Media Release / Jul 14, 2021

Novartis announces NEJM publication of positive Phase III REACH3 data for Jakavi in chronic GvHD

Read More
Featured News / Jul 06, 2021

Novartis announces Complete Response Resubmission for inclisiran New Drug Application

Read More

June

Key Release / Jun 28, 2021

Novartis appoints Rob Kowalski as Chief People & Organization Officer

Read More
Media Release / Jun 25, 2021

Sandoz announces EU launch of ready-to-dilute generic Pemetrexed to treat most prevalent form of lung cancer

Read More

Key Releases

Ad hoc announcement pursuant to article 53 Listing Rules.

Learn More

Related Links

Novartis Annual Reporting Suite

Read and download the Annual Review, the Annual Report and Form 20-F, and the Novartis in Society ESG report.

Learn More